Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Deep Rohan Chatterjee
Observed name:
Chatterjee, Deep Rohan
Institution:
National Institute of Pharmaceutical Education and Research - Ahmedabad
Observed institution:
National Institute of Pharmaceutical Education and Research - Ahmedabad
ORCID:
0000-0001-9522-0847
Observed ORCID:
0000-0001-9522-0847
OpenAlex ID:
A5014786324
Organic reactions in aqueous media catalyzed by nickel
2021
·
Dinesh Parshuram Satpute
, Gargi Nikhil Vaidya
, et al.
·
Green Chemistry
·
51
Paradigm shift of “classical” HDAC inhibitors to “hybrid” HDAC inhibitors in therapeutic interventions
2020
·
Gargi Nikhil Vaidya
, Pooja Rana
, et al.
·
European Journal of Medicinal Chemistry
·
51
Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer
2024
·
Rudradip Das
, Priyanka Pulugu
, et al.
·
Journal of Medicinal Chemistry
·
27
Oxidation states in metallocenes: A key mechanistic component in cancer alleviation
2024
·
Rudradip Das
, Deep Rohan Chatterjee
, et al.
·
Coordination Chemistry Reviews
·
11
PROTACting the kinome with covalent warheads
2022
·
Deep Rohan Chatterjee
, Saumya Kapoor
, et al.
·
Drug Discovery Today
·
11
Development of novel tetrazole-based pyruvate kinase M2 inhibitors targeting U87MG glioblastoma cells
2024
·
Moumita Ghosh Chowdhury
, Saumya Kapoor
, et al.
·
Bioorganic Chemistry
·
10
Design and synthesis of novel quinazolinone-based pyruvate kinase M2 activators as selective inhibitors of oral cancer cells
2024
·
Bhagyashri Rathod
, Swarali Joshi
, et al.
·
Journal of Molecular Structure
·
10
Roadmap to Pyruvate Kinase M2 Modulation - A Computational Chronicle
2023
·
Amit Shard
, Saumya Kapoor
, et al.
·
Current Drug Targets
·
9
Novel sulfonamides unveiled as potent anti-lung cancer agents via tumor pyruvate kinase M2 activation
2024
·
Rudradip Das
, Deep Rohan Chatterjee
, et al.
·
RSC Medicinal Chemistry
·
7
PDF
Comprehensive characterization and preclinical assessment of an imidazopyridine‐based anticancer lead molecule
2023
·
Ratik Ramesh Bulbule
, Tarang Jadav
, et al.
·
Drug Development Research
·
5
PDF
Synthesis, characterization, and microbiological evaluation of new triazolopyrimidine-based ferrocenes as potent antimicrobial prospects
2025
·
Sayali Kamble
, Deep Rohan Chatterjee
, et al.
·
Journal of Inorganic Biochemistry
·
4
Imidazopyrimidine-based pyruvate kinase M2 activator halts diabetic nephropathy progression via modulating epithelial-to-mesenchymal transition and fibrosis
2025
·
Meenakshi Jain
, Adil Ali Sayyed
, et al.
·
Chemico-Biological Interactions
·
3
IMID-284: a potent pyruvate kinase M2 inhibitor with dual anti-inflammatory and analgesic effects in intervertebral disc disease
2025
·
Gyanoday Tripathi
, Komal Bhombe
, et al.
·
European Spine Journal
·
3
Comprehensive exploration of novel imidazopyrimidine derivatives: Design, synthesis, computational assessment, and anti-breast cancer activity
2024
·
Sagarkumar Patel
, Priyanka Pulugu
, et al.
·
Journal of Molecular Structure
·
3
Ionic-molecular organocatalysis enabling allylic amination reactions
2024
·
Shyam Kumar Lokhande
, Gargi Nikhil Vaidya
, et al.
·
Cell Reports Physical Science
·
3
Sustainable synthesis and biological evaluation of novel ferrocene derivatives as metabolic modulators of pyruvate kinase M2 in oral cancer
2026
·
Vaishnavi Kalmegh
, Archit Jain
, et al.
·
Inorganic Chemistry Communications
·
2
2,5-Diazabicyclo[2.2.1]heptane in medicinal chemistry: a treasure trove of therapeutic opportunities
2026
·
Pranav Kumar Ambast
, Saumya Kapoor
, et al.
·
RSC Medicinal Chemistry
·
1
PDF
Exploring Ugi-driven tetrazole chemistry for the discovery of pyruvate kinase M2 activators in glioblastoma management
2025
·
Moumita Ghosh Chowdhury
, Ajit Kumar Sahu
, et al.
·
Journal of Molecular Structure
·
1
Coumarin–sulfonamide hybrids as PKM2 activators induce metabolic reprogramming and suppress ovarian cancer cell growth
2026
·
Deep Rohan Chatterjee
, Gourav Choudhary
, et al.
·
Bioorganic & Medicinal Chemistry
CCDC 2519792: Experimental Crystal Structure Determination
2026
·
Kalmegh, Vaishnavi
, Jain, Archit
, et al.
·
The Cambridge Structural Database
Pyruvate kinase M2 – linked metabolic pathways in pain modulation
2025
·
Vaishnavi Kalmegh
, Lahanya Guha
, et al.
·
Drug Discovery Today
The Rise and Fall of Hydroxychloroquine (HCQ) in COVID Era: A Therapeutic Journey and Synthetic Progress
2022
·
Dinesh Kumar
, Gargi Nikhil Vaidya
, et al.
·
ChemRxiv
PDF
Show more works
View as search
Works count:
23
Citation count:
212
H-index:
8
I10-index:
7
Year
Topic
Type
